R2V™ - Radial to Visceral (image)
R2V™ - Radial to Visceral (image)

R2V™ - Radial Solutions for Interventional Radiology

Radial to Visceral (R2V™) intervention contributes to patients' QOL. It causes fewer bleeding complications than the conventional femoral method.
Radial to Visceral (R2V™) intervention contributes to patients' QOL. It causes fewer bleeding complications than the conventional femoral method.
Why choose R2V™
The RAVI Registry
The RAVI Registry

The RAVI Registry

Have you heard about the outcomes of the radial access in visceral intervention, the RAVI registry?
Learn the details from Dr. Guimaraes.
Have you heard about the outcomes of the radial access in visceral intervention, the RAVI registry?
Learn the details from Dr. Guimaraes.
Outcomes of the RAVI registry
Members in Interventional Oncology team (image)
Members in Interventional Oncology team (image)

Radial to Visceral

Less-invasive solution for interventional oncology – learn how we push the boundaries in introducing RADIFOCUS™ Glidecath™, the first Terumo device for radial to visceral.
Less-invasive solution for interventional oncology – learn how we push the boundaries in introducing RADIFOCUS™ Glidecath™, the first Terumo device for radial to visceral.
Our Brand Story: R2V™
What is R2V™?

Radial to Visceral (R2V™) intervention brings various benefits over Transfemoral Artery Access (TFA), including reduced bleeding complications, easy access site management, improved patient satisfaction and the opportunity for same day discharge. Terumo offers various access devices and embolic agents for R2V™. 1-7

Products for R2V™

 

Video Library


 

The RAVI Registry

The RAVI registry, a prospective registry on 30-day outcomes with 12 month follow up was conducted to increase the data available on radial access in visceral interventions and to show that radial access is safe and feasible for a wide range of embolization procedures.

 

Learn More about RAVI Registry
Topics
How to start R2V™
How to Start R2V™
Patient and nurse (image)
Why Choose R2V™
Webinars APAC forum on R2V™
Webinars - APAC forum on R2V™
clinical evidence (image)
Clinical Evidence
Case Reports
Case report of Radial Access for Visceral Interventions
Radial Access for Visceral Intervention
Case report of Usefulness and Safety of a Radial Approach
Usefulness and Safety of a Radial Approach
Related Products
RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
RADIFOCUS™ Glidecath™ R.A.V.I. MG1/MG2
RADIFOCUS™ Guide Wire GT with gold coil
RADIFOCUS™ Guide Wire GT with gold coil
Progreat™
Progreat™
Progreat λ™
Progreat λ™
Occlusafe™
Occlusafe™
Related Topics
related_contents_transradial_intervention_560x344.png
TRI - Transradial Intervention

Reference

 

  1. Amin A, et al. Costs associated with access site and same-day discharge among Medicare beneficiaries undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2017;10(4):342-51.
  2. Schussler JM. Effectiveness and safety of transradial artery access for cardiac catheterization. Proc (Bayl Univ Med Cent). 2011; 24(3):205-209.
  3. Marso S. et al. Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention. JAMA. 2010;303(21):2156-2164.
  4. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13(5):354-362.
  5. Valgimigli M, et al. MATRIX Trial. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomized multicenter trial. Lancet. 2015;385:2465-76.
  6. Rathore S. Impact of Length and Hydrophilic Coating of the Introducer Sheath on Radial Artery Spasm During Transradial Coronary Intervention A Randomized Study. JACC Cardiovasc Interv. 2010;3(5):475-83.
  7. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/embolization